Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28109667 | 0.97 | TSHR (0.33) | TSHRALDH1A1USP2CYP3A4MAPT | |
| SCHEMBL18671478 | 0.89 | — | — | |
| SCHEMBL5868292 | 0.89 | — | — | |
| SCHEMBL2474318 | 0.87 | — | — | |
| SCHEMBL15115418 | 0.87 | — | — | |
| SCHEMBL28611328 | 0.85 | — | — | |
| SCHEMBL44830 | 0.85 | — | — | |
| SCHEMBL5716954 | 0.85 | — | — | |
| SCHEMBL28544020 | 0.85 | — | — | |
| SCHEMBL21385213 | 0.84 | CA1 (0.34) | ALDH1A1USP2CYP3A4MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103288590-A | Method for synthesizing 5-iodine-1,8-nonadiene by using ultrasonic method | UNIV JINAN | 2013-09-11 | — | — | CN | claimed |
| US-6579997-B1 | Enhanced activity of metal complexes | UAB RESEARCH FOUNDATION | 2003-06-17 | — | — | US | claimed |
| EP-1212134-A4 | METALLACROWN ETHER CATALYSTS FOR HYDROFORMYLATION | UAB RESEARCH FOUNDATION (US) | 2003-01-22 | — | — | EP | claimed |
| EP-1212134-A1 | METALLACROWN ETHER CATALYSTS FOR HYDROFORMYLATION | UAB Research Foundation (US) | 2002-06-12 | — | — | EP | claimed |
| EP-1066236-A4 | PROCESS FOR HYDROCARBONYLATIONS IN SUPERCRITICAL CARBON DIOXIDE | RES FOUNDATION OF (US) | 2001-06-06 | — | — | EP | claimed |
| WO-2001007156-A1 | METALLACROWN ETHER CATALYSTS FOR HYDROFORMYLATION | UAB RESEARCH FOUNDATION (US) | 2001-02-01 | — | — | WO | claimed |
| EP-1066236-A1 | PROCESS FOR HYDROCARBONYLATIONS IN SUPERCRITICAL CARBON DIOXIDE | The Research Foundation of State University of New York (US) | 2001-01-10 | — | — | EP | claimed |
| WO-1999050214-A1 | PROCESS FOR HYDROCARBONYLATIONS IN SUPERCRITICAL CARBON DIOXIDE | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-10-07 | — | — | WO | claimed |
| US-5962744-A | USING CATALYST COMPLEX CONTAINING TRANSITION METAL AND PHOSPHITE LIGAND | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-10-05 | — | — | US | claimed |
| US-20250346602-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | DICE ALPHA INC (US) | 2025-11-13 | — | — | US | disclosed |
| CN-120202184-A | Ionizable lipids and lipid nanoparticle compositions for delivery of nucleic acids | 海狼治疗公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-4525987-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | Dice Alpha, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2024107906-A2 | IONIZABLE LIPIDS AND LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACIDS | SEAWOLF THERAPEUTICS, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| WO-2023225664-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | DICE ALPHA, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| US-5336435-A | High polymer and ferroelectric liquid crystal composition utilizing same | IDEMITSU KOSAN CO., LTD. (JP) | 1994-08-09 | — | — | US | disclosed |
| US-5281685-A | Polyether pendant groups, polysiloxane repeating units | IDEMITSU KOSAN CO., LTD. (JP) | 1994-01-25 | — | — | US | disclosed |
| US-5264517-A | A-C copoly | IDEMITSU KOSAN CO., LTD. (JP) | 1993-11-23 | — | — | US | disclosed |
| EP-0548808-A2 | High polymer and ferroelectric liquid crystal composition utilizing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
| EP-0542305-A2 | High polymer and ferroelectric liquid crystal composition utilizing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0493601-A1 | LIQUID-CRYSTAL COPOLYMER, PRODUCTION THEREOF, DIENE COMPOUND USED IN SAID PRODUCTION, AND PRODUCTION OF SAID COMPOUND | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346602-A1 | LACTAM SUBSTITUTED IMIDAZOPYRIDAZINE IL-17A MODULATORS AND USES THEREOF | IL17A, IL15, IL18 | TSHR 4436/4885ALDH1A1 392/4885USP2 3119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.